Your browser doesn't support javascript.
loading
Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis.
Wang, Rui-Rui; Gu, Hong-Qiu; Wei, Ying-Ying; Yang, Jin-Xiang; Hou, Yi-Xin; Liu, Hui-Min; Yang, Zhi-Yun; Wang, Xian-Bo; Jiang, Yu-Yong.
Afiliação
  • Wang RR; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Gu HQ; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
  • Wei YY; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Yang JX; National Center for Healthcare Quality Management in Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Hou YX; The first Clinical School, Beijing University of Chinese Medicine, Beijing, China.
  • Liu HM; Department of Gastroenterology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
  • Yang ZY; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Wang XB; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Jiang YY; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
J Clin Transl Hepatol ; 9(5): 647-654, 2021 Oct 28.
Article em En | MEDLINE | ID: mdl-34722179
ABSTRACT
BACKGROUND AND

AIMS:

Spontaneous bacterial peritonitis (SBP) is one of the leading causes of death in patients with liver cirrhosis. We aimed to establish a prognostic model to evaluate the 1-year survival of cirrhosis patients after the first episode of SBP.

METHODS:

A prognostic model was developed based on a retrospective derivation cohort of 309 cirrhosis patients with first-ever SBP and was validated in a separate validation cohort of 141 patients. We used Uno's concordance, calibration curve, and decision curve (DCA) analysis to evaluate the discrimination, calibration, and clinical net benefit of the model.

RESULTS:

A total of 59 (19.1%) patients in the derivation cohort and 42 (29.8%) patients in the validation cohort died over the course of 1 year. A prognostic model in nomogram form was developed with predictors including age [hazard ratio (HR) 1.25; 95% confidence interval (CI) 0.92-1.71], total serum bilirubin (HR 1.66; 95% CI 1.28-2.14), serum sodium (HR 0.94; 95% CI 0.90-0.98), history of hypertension (HR 2.52; 95% CI 1.44-4.41) and hepatic encephalopathy (HR 2.06; 95% CI 1.13-3.73). The nomogram had a higher concordance (0.79) compared with the model end-stage liver disease (0.67) or Child-Turcotte-Pugh (0.71) score. The nomogram also showed acceptable calibration (calibration slope, 1.12; Bier score, 0.15±0.21) and optimal clinical net benefit in the validation cohort.

CONCLUSIONS:

This prediction model developed based on characteristics of first-ever SBP patients may benefit the prediction of patients' 1-year survival.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article